Neisseria meningitidis Group B vaccine (Emergent)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameNeisseria meningitidis Group B vaccine (Emergent)

Drug Alias NameNeisseria meningitidis Group B vaccine (Microscience)meningitis B vaccine (Emergent)meningitis B vaccine (Microscience)

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsMeningitis, Bacterial

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEmergent Europe Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEmergent Europe Inc

Active IndicationsN/A

Inactive IndicationsMeningitis, Bacterial

Other Information

ATC CodeN/A